Business Description
Medistim ASA
ISIN : NO0010159684
Compare
Compare
Traded in other countries / regions
MEDI.NorwayMD1.GermanyMEDIO.Sweden0OCD.UK IPO Date
2011-06-11Description
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia, and the Rest of the World. The firm's activity is split into three strategic operating units, Capital equipment; Lease of equipment, and Distribution and sales of third-party products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.71 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 18.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 22.58 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.4 | |||||
| 3-Year EBITDA Growth Rate | 11.3 | |||||
| 3-Year EPS without NRI Growth Rate | 14.3 | |||||
| 3-Year FCF Growth Rate | 9.4 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.82 | |||||
| Quick Ratio | 2.99 | |||||
| Cash Ratio | 1.98 | |||||
| Days Inventory | 469.01 | |||||
| Days Sales Outstanding | 59.96 | |||||
| Days Payable | 96.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.57 | |||||
| Dividend Payout Ratio | 0.8 | |||||
| 3-Year Dividend Growth Rate | 17.8 | |||||
| Forward Dividend Yield % | 2.57 | |||||
| 5-Year Yield-on-Cost % | 5.78 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 2.56 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.82 | |||||
| Operating Margin % | 24.74 | |||||
| Net Margin % | 19.51 | |||||
| FCF Margin % | 25.62 | |||||
| ROE % | 26.17 | |||||
| ROA % | 20.92 | |||||
| ROIC % | 34.9 | |||||
| ROC (Joel Greenblatt) % | 67.89 | |||||
| ROCE % | 34.58 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.96 | |||||
| PE Ratio without NRI | 31.96 | |||||
| Shiller PE Ratio | 41.27 | |||||
| Price-to-Owner-Earnings | 34.34 | |||||
| PEG Ratio | 2.35 | |||||
| PS Ratio | 6.23 | |||||
| PB Ratio | 7.62 | |||||
| Price-to-Tangible-Book | 8.68 | |||||
| Price-to-Free-Cash-Flow | 24.33 | |||||
| Price-to-Operating-Cash-Flow | 24.33 | |||||
| EV-to-EBIT | 23.44 | |||||
| EV-to-EBITDA | 16.08 | |||||
| EV-to-Revenue | 6.19 | |||||
| EV-to-FCF | 23.14 | |||||
| Price-to-Projected-FCF | 1.92 | |||||
| Price-to-DCF (Earnings Based) | 1.25 | |||||
| Price-to-DCF (FCF Based) | 0.69 | |||||
| Price-to-Median-PS-Value | 0.99 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.93 | |||||
| Price-to-Graham-Number | 3.51 | |||||
| Price-to-Net-Current-Asset-Value | 10.37 | |||||
| Price-to-Net-Cash | 45.7 | |||||
| Earnings Yield (Greenblatt) % | 4.26 | |||||
| FCF Yield % | 3.95 | |||||
| Forward Rate of Return (Yacktman) % | 19.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medistim ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 525.636 | ||
| EPS (TTM) (kr) | 5.6 | ||
| Beta | 0.1 | ||
| Volatility % | 20.66 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (kr) | 3.130394 | ||
| 20-Day SMA (kr) | 216.397932 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (kr) | 175.01833 - 266.973 | ||
| Shares Outstanding (Mil) | 18.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medistim ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medistim ASA Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medistim ASA Frequently Asked Questions
What is Medistim ASA(LTS:0OCD)'s stock price today?
The current price of LTS:0OCD is kr175.02. The 52 week high of LTS:0OCD is kr266.97 and 52 week low is kr175.02.
When is next earnings date of Medistim ASA(LTS:0OCD)?
The next earnings date of Medistim ASA(LTS:0OCD) is 2024-08-16.
Does Medistim ASA(LTS:0OCD) pay dividends? If so, how much?
The Dividend Yield %  of Medistim ASA(LTS:0OCD) is 2.57% (As of Today), Highest Dividend Payout Ratio of Medistim ASA(LTS:0OCD) was 0.8. The lowest was 0.46. And the median was 0.62. The  Forward Dividend Yield % of Medistim ASA(LTS:0OCD) is 2.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers